作者
S Roman, CP Gyawali, E Savarino, R Yadlapati, F Zerbib, J Wu, M Vela, R Tutuian, R Tatum, D Sifrim, J Keller, M Fox, JE Pandolfino, AJ Bredenoord, GERD Consensus Group, Fernando Azpiroz, Arash Babaei, Shobna Bhatia, Guy Boeckxstaens, Serhat Bor, Dustin Carlson, Donald Castell, Michele Cicala, John Clarke, Nicola De Bortoli, Vasile Drug, Marzio Frazzoni, Richard Holloway, Peter Kahrilas, Arne Kandulski, Phil Katz, David Katzka, Ravinder Mittal, Francois Mion, Luis Novais, Amit Patel, Roberto Penagini, Mentore Ribolsi, Joel Richter, Renato Salvador, Vincenzo Savarino, Jordi Serra, Felice Schnoll‐Sussman, Andre Smout, Edy Soffer, Rami Sweis, Jan Tack, Salvatore Tolone, Michael Vaezi, Philip Woodland, Yinglian Xiao
发表日期
2017/10
来源
Neurogastroenterology & Motility
卷号
29
期号
10
页码范围
1-15
简介
Background
An international group of experts evaluated and revised recommendations for ambulatory reflux monitoring for the diagnosis of gastro‐esophageal reflux disease (GERD).
Methods
Literature search was focused on indications and technical recommendations for GERD testing and phenotypes definitions. Statements were proposed and discussed during several structured meetings.
Key Results
Reflux testing should be performed after cessation of acid suppressive medication in patients with a low likelihood of GERD. In this setting, testing can be either catheter‐based or wireless pH‐monitoring or pH‐impedance monitoring. In patients with a high probability of GERD (esophagitis grade C and D, histology proven Barrett's mucosa >1 cm, peptic stricture, previous positive pH monitoring) and persistent symptoms, pH‐impedance monitoring should be performed on treatment. Recommendations are …
学术搜索中的文章
S Roman, CP Gyawali, E Savarino, R Yadlapati… - Neurogastroenterology & Motility, 2017